OTC · ACBM
Acro Biomedical Co., Ltd.
$0.03$0.00 (0.0%)
Acro Biomedical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 74.0% below the high.
Loading market information…
OTC · ONBI · USD
Stock price
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
ONE Bio Corp.’s quoted price sits in the lower half of its reported 52-week range, 83.33% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
ONE Bio Corp. functions as an agritech enterprise that, alongside its subsidiaries, employs eco-friendly manufacturing methods to develop and produce foundational chemicals, botanical extracts, health supplements, and organic goods. The company's operations are divided into two primary segments: Chemical and Herbal Extracts (CHE) and Organic Products (OP). The CHE division is dedicated to the creation, production, and market introduction of bio-ecological and non-prescription items. These products are formulated using compounds extracted from tobacco leaves and various other plant sources. Its offerings encompass chemical extracts such as Solanesol and Coenzyme Q10, in addition to herbal extracts like Resveratrol, 5-Hydroxytryptophan, and Ganoderma Tea, alongside granular and powdered fertilizers. Distribution for CHE products within China's bio-health and raw chemical intermediates sectors occurs through a network of independent third-party distributors, academic institutions, and hospital research facilities. Meanwhile, the OP unit manufactures a diverse array of health and energy beverages for both consumer and commercial use, organic food products, and fertilizers. These products, primarily bamboo-based, are marketed within the People's Republic of China. Its portfolio includes standard and vacuum-packed canned bamboo shoots, prepared mixed and seasoned vegetables, and the Japanese rice delicacy known as Kamameshi. This segment delivers its merchandise directly to supermarket chains, hotels, hospitals, and restaurants, augmented by sales through independent third-party distributors. Globally, ONE Bio Corp. exports its products to Japan, various Southeast Asian nations, European markets, and North America. Founded in 2000, the company was rebranded from ONE Holdings, Corp. to ONE Bio Corp. in November 2009 and is based in Aventura, Florida.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:17 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.03$0.00 (0.0%)
Acro Biomedical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 74.0% below the high.
$0.04$0.00 (0.0%)
Naturally Splendid Enterprises Ltd.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.03+$0.00 (0.0%)
Molecular Pharmacology (USA), Ltd.’s quoted price sits in the lower half of its reported 52-week range, 93.36% below the high.
$0.00$0.00 (0.0%)
Virtual Medical International, Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.25% below the high.
$0.00$0.00 (0.0%)
Baseline Productions, Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.0% below the high.
$0.00+$0.00 (+9,900.0%)
AXM Pharma, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Itoco Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
$0.00$0.00 (0.0%)
Amarantus BioScience Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
